Medicine
Brivaracetam 100 mg tablet
Brivaracetam 100 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted between 15°C to 30°C (59°F to…
Key facts
- Active ingredient (INN)
- Brivaracetam
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 blister pack, 60 tablets, 180 tablets and 13 more
- Manufacturers
- Zydus LifesciencesIndiaNovadoz PharmaceuticalsIndiaAurobindo PharmaIndiaScieGen PharmaceuticalsApotexAvKAREExelan PharmaceuticalsSolarisPharmaCorporation
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N03AX23 Brivaracetam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 November 2025
- Identifiers
- RxCUI 1739761, 1739768, 1739772 +2DailyMed set ID bdbb6756-654c-46f1-a85c-7d5d1a89685a, 11ca0e1d-1c0d-4357-9ebd-ee1e87185dde, d54ca946-2ddf-4a67-87c9-20a814bfd2dc +6NDC 50228-560, 72205-271, 70710-1588 +6Application ANDA219952, ANDA214921, ANDA214501 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 70710-1588-4 | Zydus LifesciencesIndia | 21 February 2026 |
| 60 tablet, film coated in 1 bottle | 70710-1588-6 | Zydus LifesciencesIndia | 21 February 2026 |
| 180 tablet, film coated in 1 bottle | 70710-1588-8 | Zydus LifesciencesIndia | 21 February 2026 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 70771-1758-4 | Zydus LifesciencesIndia | 21 February 2026 |
| 60 tablet, film coated in 1 bottle | 70771-1758-6 | Zydus LifesciencesIndia | 21 February 2026 |
| 180 tablet, film coated in 1 bottle | 70771-1758-8 | Zydus LifesciencesIndia | 21 February 2026 |
| 60 tablet, film coated in 1 bottle | 84386-072-60 | Aurobindo PharmaIndia | 25 February 2026 |
| 100 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 72205-271-06 | Novadoz PharmaceuticalsIndia | 1 February 2026 |
| 60 tablet, film coated in 1 bottle | 72205-271-60 | Novadoz PharmaceuticalsIndia | 1 February 2026 |
| 60 tablet in 1 bottle | 60505-4727-6 | Apotex | 24 February 2026 |
| 60 tablet, film coated in 1 bottle | 76282-826-60 | Exelan Pharmaceuticals | 28 July 2026 |
| 1000 tablet, film coated in 1 bottle | 50228-560-10 | ScieGen Pharmaceuticals | 27 March 2026 |
| 30 tablet, film coated in 1 bottle | 50228-560-30 | ScieGen Pharmaceuticals | 27 March 2026 |
| 60 tablet, film coated in 1 bottle | 50228-560-60 | ScieGen Pharmaceuticals | 27 March 2026 |
| 60 tablet, film coated in 1 bottle | 73473-908-60 | SolarisPharmaCorporation | 4 February 2026 |
| 60 tablet, film coated in 1 bottle | 73190-077-60 | AvKARE | 5 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Brivaracetam 100 mg tablet.
Other strengths and forms of Brivaracetam
Clinical summary
Brivaracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Brivaracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BrivaracetamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Briviact prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Briviact (in Italy: Nubriveo): European public assessment report (EPAR) · European Medicines Agency
Need Brivaracetam 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.